David Bonita

David Bonita is the current Director at TRICIDA. Prior to this, they were a Private Equity Partner at OrbiMed from June 2013 to February 2020. David has also served as a Private Equity Principal and Senior Associate at OrbiMed, and as a Financial Analyst at Morgan Stanley and UBS Investment Bank.

David Bonita received a BA in biology from Harvard University and an MBA from Columbia University - Columbia Business School. David then attended Columbia University College of Physicians and Surgeons, where they earned an MD.